Pharmaceutical

Tikcro Technologies Ltd. today reported results for the first quarter ended March 31, 2012.

Genzyme, a Sanofi company , today marked World MS Day with activities across its global network and new programs designed to mobilize and inspire people living with multiple sclerosis. Genzyme is committed to a long-term partnership with the ...

Medical Marijuana, Inc. Appoints Vincent 'Tripp' Keber to Board of Directors

Cardinal Health Specialty Solutions today announced that it will share key findings from recently conducted cancer care research at the 48th Annual Meeting of the American Society of Clinical Oncology , taking place June 1-5, at McCormick Place in ...

Investment Bridge, one of Japan's leading IR services companies, releases an updated 'Bridge Report' on FREUND CORPORATION reviewing its F2/12 earnings results and FY2/13 earnings estimates.

Connectyx Technologies Holdings Group, Inc. , www.connectyx.com, manufacturer and distributor of the MedFlash®, a Personal Health and Wellness Management System designed for maintaining personal health records , announced today the rollout of ...

Akesis LLC, a leading contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, today announced that it has named John L. Capicchioni as its new President. Mr. Capicchioni will be ...

Response Genetics, Inc. , a company focused on the development and sale of molecular diagnostic tests for cancer, announced today four presentations to be held during the 2012 American Society of Clinical Oncology Annual Meeting in Chicago, IL from ...

Ardea Biosciences, Inc. today announced that it has earned a $7.5 million milestone from Bayer HealthCare under the terms of their April 2009 global license agreement to develop and commercialize Ardea's mitogen-activated ERK kinase inhibitor ...

Bilcare and CSIR to Partner on nonClonableID Technology for Authentication of Drugs

ClearCanvas Inc., an innovative medical imaging informatics company, today announced a new partnership agreement with DPR of San Ramon, California, a technology company that delivers intelligent imaging informatics solutions for the radiology ...

Ingen Technologies, Inc. announced today that it has agreed to execute a Plan of Reorganization that would include reductions in debt and liabilities, various merger/acquisition proposals, new medical product distribution programs and finally, ...

Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced that Alan H. Auerbach, its Chairman, Chief Executive Officer, President and Founder, will present an overview of the Company at 9:30 a.m. EDT on Wednesday, June 6, ...

The spring and summer pollen seasons can be particularly troublesome for many people and this season may be more troublesome than most, according to Allergist David Hurst, M.D., PhD.

Reaxys Announces Finalists of the 2012 Reaxys PhD Prize

Infinity Pharmaceuticals, Inc. will be presenting at the Jefferies 2012 Global Healthcare Conference on June 6, 2012, at 3:00 p.m. ET in New York City.

Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Journal of Medicinal Chemistry [55:...

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the appointment of Jasbir Seehra, Ph.D., to chief scientific officer; ...

InterMune To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference

Radiotherapy practitioners in Russia can receive local-language training on advanced treatment planning techniques thanks to an initiative by Varian Medical Systems , the world leader in radiotherapy and radiosurgery. Varian is introducing courses ...